Origin Genomics founder calls embryo editing moral imperative
The claim is reported as a medical story. It is also a story about time, and the connection between the two is where the actual consequences live. When Cathy Tie, founder of Origin Genomics, calls the editing of human embryos a “moral imperative” against hereditary disease, the argument is framed at the scale of a single patient: one child, one diagnosis, one disease prevented. But an edit made in an embryo is not a treatment administered to a person. It is a change written into a lineage, and the relevant instrument for measuring it is not a clinical trial but a genealogy.
On a mountainside, a plant’s position means little until one records altitude, temperature, soil and the species above and below it. The same discipline applies here. An embryo edit has at least four columns in its data sheet, and the public debate fills in only the first.
The first column is the disease itself, and here the case is strong. Hereditary disorders are not abstractions. There is a particular kind of waiting room, with a mother holding a folder of genetic reports thick as a field notebook, who already knows which of her relatives the condition took and at what age. To tell her that the risks of intervention are “controversial” is to offer her a word where she wanted a remedy. Any honest analysis must begin by granting this.
The second column is the alternative, and this is where the imperative begins to thin. For most couples carrying a known hereditary mutation, embryos can already be screened during IVF and an unaffected one selected. That requires no editing, only choosing. The cases where selection genuinely fails are narrower: couples in which every embryo will carry the disease, because of how the parents’ genes combine. That is the strongest version of the argument for editing, and I accept it as real. But note what it does to the word “imperative.” A moral imperative that applies to a small subset of families, for whom the alternative is adoption, donor gametes, or accepting the risk, is a serious claim about a rare situation. It is not a general mandate. The rhetoric has been measured at the summit and reported as if it held across the whole mountain.
The third column is the error term. Editing tools can make changes at unintended sites, and an embryo edited at an early stage can become a mosaic, with some cells altered and others not. In somatic therapy, an error lives and dies with one patient. In the germline, an error is heritable. It is the difference between a flood that damages one season’s harvest and a change to the course of the river itself. A mistake cannot be recalled once the child has children, and the data on whether the edit worked arrive over decades, long after any company’s funding round has closed.
Which brings me to the fourth column: the incentives of the one making the measurement. Origin Genomics is a company, and Cathy Tie is its founder. When the language of moral necessity comes from the party that would sell the procedure, the claim still needs weighing on its merits, but its origin is part of the data. A botanist who owns the plantation should not be the only one counting the trees. Nor is the regulatory terrain uniform. Germline editing is prohibited or tightly restricted in many jurisdictions, which means that demand, if it grows, will flow toward wherever the rules are thinnest, as water seeks the lowest ground. The moral argument, made loudly in one place, creates a market that settles quietly somewhere else.
Draw these four columns together and the picture changes. The imperative is real for a small number of families. The risks are borne by people not yet born. The evidence arrives on a generational clock, and the enthusiasm arrives on a commercial one. None of this proves editing must never happen. It proves that “moral imperative” is the wrong unit of measurement, because it records the benefit at the scale of one life and the cost at the scale of none.
The honest instrument here is not a slogan but a ledger kept across generations: who was edited, what changed, what their children inherited, and who was watching. I once carried a barometer up a volcano because I did not trust anyone’s estimate of the height. The founders of Origin Genomics are asking us to trust theirs, from the foot of a mountain whose summit none of us will live to reach. The readings that settle this question will be taken by a child’s grandchildren, holding the same thick folder of genetic reports, and reading a line that someone else chose to write.